Rozšírené hľadanie
Štvrtok 25. Apríl 2024 |
meniny má Marek

Reuters.com | Regulatory News 30.07.2014 02:36 July 29 - Regeneron Pharmaceuticals Inc said the U.S. Food and Drug Administration has approved the expanded use of its eye drug Eylea for the treatment of diabetic macular edema.